Abstract
To the Editor: Neuropsychiatric symptoms in patients with systemic lupus erythematosus (SLE) present a challenge to the clinician because they can be caused by the underlying disease (neuropsychiatric SLE; NPSLE) or coexist independently1. No specific diagnostic test is available for NPSLE. Reports on the associations between specific antinuclear autoantibodies and distinct NPSLE syndromes have been conflicting2,3,4,5, perhaps because of the laboratory tests used to detect these autoantibodies. New multiplex technologies for the detection of autoantibodies have emerged in the last years and might be helpful in diagnosing NPSLE. We hypothesized that a cluster of autoantibodies could be associated with a specific NPSLE syndrome or with focal or diffuse NPSLE manifestations. Therefore we used an addressable laser bead immunoassay test in patients who visited the NPSLE clinic in Leiden, the Netherlands, a tertiary referral center for patients with SLE who have neuropsychiatric symptoms. Between September 2007 and February 2012, 133 patients with SLE who had neuropsychiatric symptoms were evaluated and diagnosed consecutively by a multidisciplinary team6. All patients fulfilled the revised SLE criteria of the American College … Address correspondence to Dr. E.J.M. Zirkzee, Department of Rheumatology, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands. E-mail: E.J.M.Zirkzee{at}LUMC.nl